Not an SEC registrant

Osivax

Customers

1 federal agency

Suppliers

None disclosed

Largest customer

—

No % disclosed

Named-customer revenue

—

No estimate available

Federal obligations

$20.2M

FY2025 · USAspending.gov

Band height is the estimated dollar value: the disclosed share × the discloser's revenue for that period (latest full year where available) or federal dollars obligated. Each side is scaled on its own; dashed outlines are named without a figure. Click a band to open its source.

Federal contracts 1

Agencies that awarded contracts to this company, from USAspending.gov. Dollars are obligated amounts as reported, not estimates; $20.2M in the latest fiscal year shown per agency.

Agency	Obligated	Fiscal year	Awards	Trend	Largest award
Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response	$20.2M	FY 2025	2		75A50125C00008
OSIVAX - CLINICAL PROOF OF CONCEPT OF OVX836, A SINGLE-SHOT BROADLY PROTECTIVE INFLUENZA A VACCINE FOR IMMEDIATE PROTECTION AGAINST EMERGING PANDEMIC STRAINS Award 75A50125C00008 on USAspending.gov ↗ Largest of 2 awards in FY2025: $19.5M obligated

Alerts are coming

Get an email when Osivax's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.